Back to search results
NCT05015881

Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder

Enrolling by Invitation
PHASE2Ages 21–65InterventionalBasic science
University of Pennsylvania
~20 participants
Updated 2026-03-30 on ClinicalTrials.gov
What's tested:Ketone Ester "(R)-3-hydroxybutyl (R)-3-hydroxybutyrate"FDG

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
FDG uptake (CMRg) in the brain and heart
Measured over 4 hours

Conditions

Alcohol Use Disorder (AUD)
Alcohol Drinking

Explore related trials

Alcohol use disorder

Where it's being run

1 sites across 1 states
Pennsylvania1

Study leadership

  • Corinde E Wiers, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • FDG uptake (CMRg) in the brain and heart4 hours

    The primary outcome measure to be analyzed is a comparisons of AUD subjects and healthy control subjects in the amount of FDG uptake (CMRg metabolic rate of glucose) in brain and heart.